Available from week 10 of pregnancy, the NIPT by GenePlanet gives you an early option to know more about the genetic health of your baby.
Compared to traditional screening tests, the NIPT by GenePlanet offers higher accuracy and lower false positive rates. This means that less women will undergo invasive diagnostic procedures such as amniocentesis or chorionic villus sampling which carry a 1-2% risk of miscarriage.
NIPT by GenePlanet is non-invasive and therefore poses no risk to the mother or baby.
The NIPT by GenePlanet is available to any pregnant woman from the 10th week of pregnancy but is particularly suitable for pregnant women who exhibit certain indications which are highlighted below.
Prior to undertaking any non-invasive prenatal testing, you should consult a qualified healthcare professional regarding any risks, diagnoses, treatment and/or any other potentially relevant healthcare issues.
NSGC (National Society of Genetic Counselors)
The NSGC supports NIPT as an option for patients whose pregnancies are considered to be at an increased risk of certain chromosome abnormalities. Patients whose NIPT results are abnormal, or who have other factors suggestive of a chromosome abnormality, should receive genetic counselling and be given the option of standard confirmatory diagnostic testing.